Ownership Submission
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
Pfaffle Antony
   2. Issuer Name and Ticker or Trading Symbol
CorMedix Inc. [CRMD] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
Interim Chief Medical Officer
(Last)
(First)
(Middle)
C/O CORMEDIX INC., 745 ROUTE 202-206, SUITE 303		 3. Date of Earliest Transaction (Month/Day/Year)
05/13/2016
(Street)

BRIDGEWATER, NJ 08807		 4. If Amendment, Date Original Filed(Month/Day/Year)
 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)		 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code
(Instr. 8)		 4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)		 5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)		 6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)		 7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock, $0.001 par value per share 05/13/2016   M   60,000 A $ 0.68 60,000 D  
Common Stock, $0.001 par value per share 05/13/2016   S   20,000 D $ 2.5782 (1) 40,000 D  
Common Stock, $0.001 par value per share 05/13/2016   S   20,000 D $ 2.6783 (2) 20,000 D  
Common Stock, $0.001 par value per share 05/16/2016   S   5,000 D $ 2.8356 (3) 15,000 D  
Common Stock, $0.001 par value per share 05/16/2016   S   5,000 D $ 2.8406 (4) 10,000 D  
Common Stock, $0.001 par value per share 05/16/2016   S   5,000 D $ 2.8336 (5) 5,000 D  
Common Stock, $0.001 par value per share 05/16/2016   S   5,000 D $ 2.6574 (6) 0 D  

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)		 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code
(Instr. 8)		 5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)		 6. Date Exercisable and Expiration Date
(Month/Day/Year)		 7. Title and Amount of Underlying Securities
(Instr. 3 and 4)		 8. Price of Derivative Security
(Instr. 5)		 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)		 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)		 11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (right to buy) $ 2.27               (3) 04/01/2024 Common Stock, $0.001 par value per share 100,000   100,000 D  
Stock Option (right to buy) $ 2.02               (7) 01/09/2024 Common Stock, $0.001 par value per share 100,000   100,000 D  
Stock Option (right to buy) $ 2.02               (8) 01/09/2024 Common Stock, $0.001 par value per share 30,000   30,000 D  
Stock Option (right to buy) $ 0.9               (9) 03/22/2023 Common Stock, $0.001 par value per share 210,000   210,000 D  
Stock Option (right to buy) $ 0.68 05/13/2016   M   60,000     (10) 12/05/2022 Common Stock, $0.001 par value per share 250,000 $ 0 190,000 D  
Stock Option (right to buy) $ 2.1               (11) 01/14/2021 Common Stock, $0.001 par value per share 30,000   30,000 D  
Stock Option (right to buy) $ 3.125               (12) 03/30/2020 Common Stock, $0.001 par value per share 20,000   20,000 D  
Stock Option (right to buy) $ 5               (13) 02/24/2025 Common Stock, $0.001 par value per share 75,000   75,000 D  

Reporting Owners

Reporting Owner Name / Address Relationships
 Director  10% Owner  Officer  Other
Pfaffle Antony
C/O CORMEDIX INC.
745 ROUTE 202-206, SUITE 303
BRIDGEWATER, NJ 08807		   X     Interim Chief Medical Officer  

Signatures

 Alexander M. Donaldson, with a Power of Attorney for Antony E. Pfaffle, M.D.   05/17/2016
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.55 to $2.65, inclusive.
(2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.65 to $2.74, inclusive.
(3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.83 to $2.85, inclusive.
(4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.83 to $2.85, inclusive.
(5) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.83 to $2.85, inclusive.
(6) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.65 to $2.68, inclusive.
(7) The options vested 100% on January 10, 2014.
(8) The options vest in full on the first anniversary of the date of grant.
(9) These options vest based on performance milestones running through December 31, 2014.
(10) These options vested as follows: (a) fifty percent (50%) on the date of the issuance of the CE mark certification, which occurred on July 5th, 2013, and (b) fifty percent (50%) on December 31, 2013.
(11) These options vested on January 14, 2012.
(12) These options vested as follows: 1/3 on March 30, 2010; an additional 1/3 on March 30, 2011; and the remaining 1/3 on March 30, 2012.
(13) These options were granted on February 24, 2015, and vested immediately.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.